Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's Disease

Recent news which mentions Alzheimer's Disease

< Previous 1 2 3 Next >
Medicare details plan to cover Alzheimer's treatments
Tags Biotechnology Health care industry Alzheimer's disease
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Biogen Inc US: News Business News
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Breaking News: Business Health care industry Alzheimer's disease
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Health care industry Biotechnology Alzheimer's disease
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Business News US: News Pharmaceuticals
From CNBC.com News
March 2023 Miscellany
Tags Eisai (ESALY) GlaxoSmithKline (GSK) Cancer
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
Tags Parkinson's Disease Cassava Sciences (SAVA) Doc Gumshoe
From Stock Gumshoe
Relevant Updates – December 2022
Tags Biogen Idec (BIIB) Alzheimer's Disease Bavarian Nordic (BAVA/CO BVNRY BVNKF)
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags why it's moving Trading Ideas News
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
Tags Neuroscience Make It / Life Dementia
From CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
Tickers SPRC
Tags medical cannabis Cannabis Alzheimer's disease
From Benzinga
Odd & Ends – October 2022
Tags Amylx Pharmaceuticals (AMLX) Biogen Idec (BIIB) Alzheimer's Disease
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags CGTX NVO Movers
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Marc Goodman lecanemab SVB Leerink
From Benzinga
Following Up on Your Suggestions – September 2022
Tickers DIET
Tags NervGen Pharma (NGEN/V NGENF) Johnson and Johnson (JNJ) diet
From Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
Tickers DGX
Tags Quest Diagnostics Alzheimer's Disease NYSE:DGX
From 3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
Tickers CGTX
Tags Market News Exclusives News
From Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
Tags ProMIS Neurosciences (PMN/TO ARFXF) INmune Bio (INMB) Alzheimer's Disease
From Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Tickers ABBV ALEC
Tags General Small Cap ABBV
From Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
Tags Alzheimer's Disease Guest Articles TauRX Pharmaceuticals
From Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags News Health Care Alzheimer's disease
From Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
Tags Biogen Idec (BIIB) Doc Gumshoe Alzheimer's Disease
From Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Alzheimer's disease Health Care Benzinga
From Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
Tickers SAVA
Tags Small Cap Health Care Alzheimer's disease
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Tickers LGVN
Tags Phase 2 Trial LGVN Exclusives
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Market News Health Care Alzheimer's disease
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags Phase 1 Trial General LGVN
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags ESALF Biotech Benzinga
From Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags Phase 3 Trial General Market News
From Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
Tickers PRTA
Tags Small Cap General Parkinson’s Disease
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.